Clinical trial
SHARE: Simple HAART With Abacavir, Reyataz, and Epivir
NCT00426296 · Clinical Alliance for Research & Education - Infectious Diseases, LLC., Other · Unknown status
Key facts
| NCT number | NCT00426296 |
|---|---|
| Title | SHARE: Simple HAART With Abacavir, Reyataz, and Epivir |
| Official title | An Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of a Fixed-Dose Combination of Abacavir 600 mg/Lamivudine 300 mg Once-Daily in Combination With Atazanavir 300 mg + Ritonavir 100 mg Once-Daily in Antiretroviral-Naïve HIV-1 Infected Subjects With Continuing Evaluation of… |
| Lead sponsor | Clinical Alliance for Research & Education - Infectious Diseases, LLC., Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections, Lipodystrophy |
| Intervention type | Drug |
| Interventions | atazanavir (Reyataz), ritonavir (Norvir) |
| Start date | Aug 1, 2006 |
| First posted | Jan 24, 2007 |
| Last update posted | Nov 1, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: